“…[1,2] However,e fforts to transform the liposome from asingular drug delivery vehicle into am ultimodal theranostics nanoplatform have centered around an "all-in-one" approach, wherein different functional moieties are combined for multifunctional utility.T his inherent complexity led to significant challenges in their clinical translation. [4] Previously developed porphyrin and porphyrin analog-based lipids such as bacteriochlorophylllipid [5,6] and texaphyrin-lipid [7,8] have shown unique stimuliresponsive properties and versatile metal-chelation capabilities,r espectively,f or cancer imaging.W ee nvision that it is possible for an on-porphyrin-based dye-lipid building block, such as aza-BODIPY,t oassemble into aliposomal structure that introduces novel nanoscale optical properties and broadens the purview of "one-for-all" lipid nanoparticles. [4] Previously developed porphyrin and porphyrin analog-based lipids such as bacteriochlorophylllipid [5,6] and texaphyrin-lipid [7,8] have shown unique stimuliresponsive properties and versatile metal-chelation capabilities,r espectively,f or cancer imaging.W ee nvision that it is possible for an on-porphyrin-based dye-lipid building block, such as aza-BODIPY,t oassemble into aliposomal structure that introduces novel nanoscale optical properties and broadens the purview of "one-for-all" lipid nanoparticles.…”